VICTOZA DIABETES DRUG LINKED TO LIFE-THREATENING CONDITIONS
Victoza (liraglutide) is a pharmaceutical drug prescribed to treat type 2 diabetes. Manufactured by Novo Nordisk, Victoza is administered once daily subcutaneously, or under the skin, via injection. The U.S. Food and Drug Administration approved the diabetes medication in 2010.
Incretin mimetics, such as Victoza and Byetta, act like incretin hormones, which stimulate insulin production in the body only when required. Incretin mimetics can also suppress appetite by slowing the absorption of glucose into the bloodstream. These diabetes medications have been approved by the United States Food and Drug Administration (FDA) to be used alongside other diabetes drugs.
There are side effects associated with all incretin mimetics, including:
- Loss of appetite
SEVERE SIDE EFFECTS ASSOCIATED WITH VICTOZA USE
Victoza has several life-threatening side effects, including:
- Thyroid tumors
- Kidney failure
INCRETIN MIMETIC DRUGS LINKED TO SEVERE PANCREATITIS
The first incretin mimetic drugs hit the shelves in 2005 with the introduction of Byetta. Shortly thereafter, the FDA received many reports of patients developing acute pancreatitis. The agency issued a warning regarding the drugs link, but months later, the FDA had to issue another warning — Byetta could cause severe pancreas inflammation, including necrotizing and hemorrhagic pancreatitis. This warning came just three years after the introduction of incretin mimetic drugs, and now every incretin mimetic drug, including Victoza, has the warning on its label.
FDA INVESTIGATING RISK OF CANCER IN VICTOZA, INCRETIN MIMETIC DRUGS
The FDA announced that they are investigating a possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from the use of incretin mimetic drugs. In 2013, the agency announced that they are reviewing unpublished research findings that suggest a link between the diabetes medications and pancreatic duct metaplasia. The findings were based on an examination of pancreatic tissue taken from patients after their death. The investigation includes several diabetes medications in the incretin mimetic classification.
Although the FDA has not drawn any conclusions regarding the potential link as of yet, the investigation signals the potential of another risk associated with Victoza and similar dangerous diabetes drugs.
HAVE YOU BEEN HARMED BY THE DANGEROUS DIABETES MEDICATION VICTOZA?
Diabetes medications are prescribed to help people treat their condition and improve their outlook. The last thing that people should expect is to be further injured or maligned after taking a drug — especially a drug that they were told would be safe to consume. If you or a loved one has been injured after taking Victoza, contact Thomas J. Henry. Our team of experienced dangerous drug attorneys are available 24/7, nights and weekends to hear your claim.